Nanjoo Suh

9.9k total citations
108 papers, 7.9k citations indexed

About

Nanjoo Suh is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Nanjoo Suh has authored 108 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Molecular Biology, 32 papers in Genetics and 28 papers in Oncology. Recurrent topics in Nanjoo Suh's work include Estrogen and related hormone effects (29 papers), Genomics, phytochemicals, and oxidative stress (19 papers) and Antioxidant Activity and Oxidative Stress (17 papers). Nanjoo Suh is often cited by papers focused on Estrogen and related hormone effects (29 papers), Genomics, phytochemicals, and oxidative stress (19 papers) and Antioxidant Activity and Oxidative Stress (17 papers). Nanjoo Suh collaborates with scholars based in United States, South Korea and United Kingdom. Nanjoo Suh's co-authors include Michael B. Sporn, Gordon W. Gribble, Tadashi Honda, Charlotte R. Williams, Chung S. Yang, Renee Risingsong, Yongping Wang, Hong Jin Lee, Agnes M. Rimando and J. Wahler and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Nanjoo Suh

107 papers receiving 7.7k citations

Peers

Nanjoo Suh
Chapla Agarwal United States
Shivendra V. Singh United States
Richard C. Moon United States
Margaret M. Manson United Kingdom
Fung‐Lung Chung United States
Vaqar M. Adhami United States
Nanjoo Suh
Citations per year, relative to Nanjoo Suh Nanjoo Suh (= 1×) peers Mahadev Rao

Countries citing papers authored by Nanjoo Suh

Since Specialization
Citations

This map shows the geographic impact of Nanjoo Suh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nanjoo Suh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nanjoo Suh more than expected).

Fields of papers citing papers by Nanjoo Suh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nanjoo Suh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nanjoo Suh. The network helps show where Nanjoo Suh may publish in the future.

Co-authorship network of co-authors of Nanjoo Suh

This figure shows the co-authorship network connecting the top 25 collaborators of Nanjoo Suh. A scholar is included among the top collaborators of Nanjoo Suh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nanjoo Suh. Nanjoo Suh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zong, Wei‐Xing, et al.. (2023). Endocrine‐disrupting compounds and metabolomic reprogramming in breast cancer. Journal of Biochemical and Molecular Toxicology. 37(12). e23506–e23506. 3 indexed citations
2.
Suh, Nanjoo, et al.. (2023). Isothiocyanate-rich moringa seed extract reduces skin inflammation in mouse ear edema model. Phytomedicine Plus. 3(4). 100479–100479. 4 indexed citations
3.
Kuo, Hsiao‐Chen Dina, Renyi Wu, Md Shahid Sarwar, et al.. (2022). DNA Methylome and Transcriptome Study of Triterpenoid CDDO in TPA-Mediated Skin Carcinogenesis Model. The AAPS Journal. 24(6). 115–115. 1 indexed citations
4.
Minden, Audrey, Philip Furmanski, Min Ji Bak, et al.. (2020). Analysis of the Transcriptome: Regulation of Cancer Stemness in Breast Ductal Carcinoma In Situ by Vitamin D Compounds. Cancer Prevention Research. 13(8). 673–686. 13 indexed citations
5.
Bak, Min Ji, Soumyasri Das Gupta, J. Wahler, et al.. (2017). Inhibitory Effects of γ- and δ-Tocopherols on Estrogen-Stimulated Breast Cancer In Vitro and In Vivo. Cancer Prevention Research. 10(3). 188–197. 26 indexed citations
6.
Gupta, Soumyasri Das, Misaal Patel, J. Wahler, et al.. (2017). Differential Gene Regulation and Tumor-Inhibitory Activities of Alpha-, Delta-, and Gamma-Tocopherols in Estrogen-Mediated Mammary Carcinogenesis. Cancer Prevention Research. 10(12). 694–703. 11 indexed citations
7.
Bak, Min Ji, Soumyasri Das Gupta, J. Wahler, & Nanjoo Suh. (2016). Role of dietary bioactive natural products in estrogen receptor-positive breast cancer. Seminars in Cancer Biology. 40-41. 170–191. 69 indexed citations
8.
Wahler, J. & Nanjoo Suh. (2015). Targeting HER2 Positive Breast Cancer with Chemopreventive Agents. Current Pharmacology Reports. 1(5). 324–335. 21 indexed citations
9.
Wahler, J., Jae Young So, Fang Liu, et al.. (2014). Inhibition of the Transition of Ductal Carcinoma In Situ to Invasive Ductal Carcinoma by a Gemini Vitamin D Analog. Cancer Prevention Research. 7(6). 617–626. 14 indexed citations
10.
So, Jae Young & Nanjoo Suh. (2014). Targeting cancer stem cells in solid tumors by vitamin D. The Journal of Steroid Biochemistry and Molecular Biology. 148. 79–85. 45 indexed citations
11.
Wahler, J., Jae Young So, Larry C. Cheng, et al.. (2014). Vitamin D compounds reduce mammosphere formation and decrease expression of putative stem cell markers in breast cancer. The Journal of Steroid Biochemistry and Molecular Biology. 148. 148–155. 43 indexed citations
12.
Smolarek, Amanda K., Jae Young So, Ah‐Ng Tony Kong, et al.. (2012). Dietary Administration of δ- and γ-Tocopherol Inhibits Tumorigenesis in the Animal Model of Estrogen Receptor–Positive, but not HER-2 Breast Cancer. Cancer Prevention Research. 5(11). 1310–1320. 41 indexed citations
13.
Huang, Ying, Tin Oo Khor, Limin Shu, et al.. (2012). A γ-tocopherol-Rich Mixture of Tocopherols MaintainsNrf2Expression in Prostate Tumors of TRAMP Mice via Epigenetic Inhibition of CpG Methylation,. Journal of Nutrition. 142(5). 818–823. 65 indexed citations
14.
DeCastro, Andrew, Amanda K. Smolarek, Jae Young So, et al.. (2010). Dietary intake of pterostilbene, a constituent of blueberries, inhibits the  -catenin/p65 downstream signaling pathway and colon carcinogenesis in rats. Carcinogenesis. 31(7). 1272–1278. 114 indexed citations
15.
Ju, Jihyeung, Sonia C. Picinich, Zhihong Yang, et al.. (2009). Cancer-preventive activities of tocopherols and tocotrienols. Carcinogenesis. 31(4). 533–542. 202 indexed citations
16.
Lee, Hong Jin, Hao Liu, Catherine Goodman, et al.. (2006). Gene expression profiling changes induced by a novel Gemini Vitamin D derivative during the progression of breast cancer. Biochemical Pharmacology. 72(3). 332–343. 55 indexed citations
17.
Suh, Nanjoo, Anita B. Roberts, Stephanie Birkey Reffey, et al.. (2003). Synthetic triterpenoids enhance transforming growth factor beta/Smad signaling.. PubMed. 63(6). 1371–6. 76 indexed citations
18.
Schimmer, Aaron D., Shinichi Kitada, Mark D. Minden, et al.. (2003). Synthetic triterpenoids activate a pathway for apoptosis in AML cells involving downregulation of FLIP and sensitization to TRAIL. Leukemia. 17(11). 2122–2129. 72 indexed citations
19.
Honda, Tadashi, Yukiko Honda, Frank G. Favaloro, et al.. (2002). A novel dicyanotriterpenoid, 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-onitrile, active at picomolar concentrations for inhibition of nitric oxide production. Bioorganic & Medicinal Chemistry Letters. 12(7). 1027–1030. 129 indexed citations
20.
Bore, Lothar, et al.. (1999). Novel synthetic oleanane triterpenoids: A series of highly active inhibitors of nitric oxide production in mouse macrophages. Bioorganic & Medicinal Chemistry Letters. 9(24). 3429–3434. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026